Immunochina Pharmaceuticals

Beijing, China · Founded 2015 · Privately Held (backing)

Developer of gene cell medicine technology intended for malignant tumor treatment. Immunochina Pharmaceuticals is based in Beijing, China and was founded in 2015. Its last reported valuation was $215 million in Sep 2020. It has raised $45 million.

Last reported valuation

$215.3M

Oct 2026

Priced at

—

Total raised

$45.0M

Last round

—

How much has Immunochina Pharmaceuticals raised?

$45.0Macross 0 recorded rounds

Free account

More of Immunochina Pharmaceuticals with a free account

·The complete investor list: 21 names
·Watch Immunochina Pharmaceuticals: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Immunochina Pharmaceuticals investors

21 investors are on record for Immunochina Pharmaceuticals, including Cowin Capital, Legend Capital, SJ Jiacheng Investment Management and GF Qianhe. By type, the record holds 3 venture capital firms and 2 funds of funds.

For fundraisers

Raising for a company like Immunochina Pharmaceuticals?

21 investors have backed Immunochina Pharmaceuticals.

See all 21 investors →

Frequently asked about Immunochina Pharmaceuticals

How much has Immunochina Pharmaceuticals raised?: Immunochina Pharmaceuticals has raised $45.0M in total across 0 recorded funding rounds.